Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels

Molecular Brain Research

Volumn 35, Issue 1-2, 1996, Pages 69-76

  Buckland, Paul R ^a   Spurlock, Gillian ^a   McGuffin, Peter ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

2 phenyletylamine; Dopa decarboxylase; Psychosis; Psychotogenesis; Schizophrenia; Tryptamine

Indexed keywords

AMPHETAMINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; NEUROLEPTIC AGENT; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; RNA ANALYSIS; SCHIZOPHRENIA;

ANIMALIA;

EID: 0030029387     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00182-R     Document Type: Article

References (41)

1. Anderson, G.M., Gerner, R.H., Cohen, D.J. and Fairbanks, L., Central tryptamine turnover in depression, schizophrenia and anorexia: measurement of indoleacetic acid in cerebrospinal fluid, Biol. Psychiatry, 19 (1984) 1427-1435.
2. 3 receptor mRNA levels in rat brain following antipsychotic treatment, Psychopharmacology, 106 (1992) 479-483.
3. Buckland, P.R., O'Donovan, M.C. and McGuffin, P., Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels, Neuropharmacology, 32 (1993) 901-907.
4. Dabadie, H., Mons, N. and Geffard, M., Simultaneous detection of tryptamine and dopamine in rat substantia nigra and raphe nuclei using specific antibodies, Brain Res., 512 (1990) 138-142.
5. Davis, B.A., Shrikande, S., Paralikar, V.P., Hirsch, S.R., Durden, D.A. and Boulton, A.A., Phenylacetic acid in CSF and serum in Indian schizophrenic patients, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 15 (1991) 41-47.
6. Deutch, A.Y., Moghaddam, B., Innis, R.B., Krystal, J.H., Aghajanian, G.K., Bunney, B.S. and Charney D.S., Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia, Schizophr. Res., 4 (1991) 121-156.
7. Durden, D.A. and Philips, S.R., Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain, J. Neurochem., 54 (1980) 1725-1732.
8. Dyck, L.E., Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor, Life Sci., 44 (1989) 1149-1156.
9. Dyck, L.E. and Boulton, A.A., Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex, Neurochem. Res., 14 (1989) 63-67.
10. Eaton, M.J., Gudehithlu, K.P., Quach, T., Silva, C.P., Hadjiconstantinou, M. and Neff, N.H., Distribution of aromatic L-amino acid decarboxylase mRNA in mouse brain by in situ hybridisation histology, J. Comp. Neurol., 337 (1993) 640-654.
11. Gilka, L., Schizophrenia: a disorder of tryptophan metabolism, Acta Psychiatr. Scand., Suppl. 258 (1975).
12. Greenshaw, A.J., Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: implications for psychotherapeutic drug action, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 13 (1989) 431-443.
13. Janowsky, D.S. and Risch, C., Amphetamine psychosis and psychotic symptoms, Psychopharmacology, 65 (1979) 73-77.
14. Jones, R.S., Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?, Prog. Neurobiol., 19 (1982) 117-139.
15. Juorio, A.V., Brain β-phenylethylamine: localisation, pathways and interrelation with catecholamines. In: M. Sandler, A. Dahlstrom and R.H. Belmaker (Eds.), Progress in Catecholamine Research. Part B: Central Aspects. Neurology and Neurobiology, Vol. 42B, Alan R. Liss, New York, 1988, pp. 433-437.
16. Juorio, A.V., Greenshaw, A.J. and Wishart, T.B., Reciprocal changes in striatal dopamine and β-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors, Naunyn-Schmiedeberg's Arch. Pharmacol., 338 (1988) 644-648.
17. Juorio, A.V., Greenshaw, A.J., Zhu, M.Y. and Paterson, I.A., The effects of some neuroleptics and D-amphetamine on striatal 2-phenylethylamine in the mouse, Gen. Pharmacol., 22 (1991) 407-413.
18. Juorio, A.V., Paterson, I.A., Zhu, M.Y. and Matte, G., Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum, J. Neurochem., 56 (1991) 213-220.
19. Komissarov, I.V., Abramets, I.I. and Samoilovich, I.M., (1989) Tryptamine as an endogenous modulator of neuronal sensitivity to serotonin, Neirofiziologiia, 21 (1989) 352-357.
20. Li, X.M., Juorio, A.V. and Boulton, A.A., NSD-1015 alters the gene expression of aromatic L-amino acid decarboxylase in rat PC12 pheochromocytoma cells, Neurochem. Res., 18 (1993) 915-919.
21. Mousseau, D.D., (1993) Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatrie disorders, Metab. Brain Dis., 8 (1993) 1-44.
22. Mumford, J.P. and Cannon, D.J., Vigabatrin, Epilepsia, 35 Suppl. 5 (1994) S25-S28.
23. Nudel, U., Zakut, R., Shani, M., Neuman, S., Levy, Z. and Yaffe D., The nucleotide sequence of the rat cytoplasmic beta-actin gene, Nucleic Acids Res., 11 (1983) 1759-1771.
24. Ono, H., Ito, H. and Fukuda, H., 2-Phenylethylamine and methamphetamine enhance the spinal monosynaptic reflex by releasing noradrenaline from the terminals of descending fibres, Jpn. J. Pharmacol., 55 (1991) 359-366.
25. O'Reilly, R., Davis, B.A., Durden, D.A., Thorpe, L., Machnee, H. and Boulton, A.A., Plasma phenylethylamine in schizophrenic patients, Biol. Psychiatry, 30 (1991) 145-150.
26. Ortmann, R., Schaub, M., Felner, A., Lauber, J., Christen, P. and Waldmeier, P.C., Phenylethylamine-induced stereotypies in the rat: a behavioural test system for assessment of MAO-B inhibitors, Psychopharmacology, 84 (1984) 22-27.
27. Paetch, P.R., Baker, G.B. and Greenshaw, A.J., Induction of functional down-regulation of beta-adrenoreceptors in rats by 2-phenylethylamine, J. Pharmaceut. Sci., 82 (1993) 22-24.
28. Paterson, I.A., Juorio, A.V. and Boulton, A.A., 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?, J. Neurochem., 55 (1990) 1827-1837.
29. Paterson, I.A., Juorio, A.V., Berry, M.D. and Zhu, M.Y., Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum, J. Pharmacol. Exp. Ther., 258 (1991) 10191026.
30. Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara, H., Andermann, F., Bachneff, S., Cumming, P., Diksic, M., Dyve, S.E., Etienne, P., Evans, A.C., Lal, S., Shevell, M., Savard, G., Wong, D.F., Chouinard, G. and Gjedde, A., Elevated dopa decarboxylase activity in living brain of patients with psychosis, Proc. Natl. Acad. Sci. USA, 91 (19914) 11651-11654.
31. 2 adrenoreceptors, J. Neurochem., 52 (1989) 647-652.
32. Rossetti, Z.L., Silva, C.P., Krajnc, D., Neff, N.H. and Hadjiconstantinou, M., Aromatic L-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina, J. Neurochem., 54 (1990) 787-791.
33. Sande, J.W., Hart, Y.M., Trimble, M.R. and Shorvon, S.D., Vigabatrin and psychosis, J. Neurol. Neurosurg. Psychiatry, 54 (1991) 435-9.
34. Spurlock, G., Buckland, P.R., O'Donovan, M.C. and McGuffin, P., Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter, Neuropharmacology, 33 (1994) 433-440.
35. Tanaka, T., Horio, Y., Taketoshi, M., Imamura, I., Ando-Yamamoto, M., Kangawa, K., Matsuo, H., Kuroda, M. and Wada, H., Molecular cloning and sequencing of a cDNA of dopa decarboxylase: Partial amino acid homologies with other enzymes synthesising catecholamines, Proc. Natl. Acad. Sci. USA, 86 (1989) 8142-8146.
36. 15N]tryptamine in schizophrenia patients, J. Chromatogr., 289 (1984) 223-9.
37. Yukitake, A., Amphetamine psychosis in Tokyo - its clinical features and social problems, Folia Psychiatr. Neurol. Japon., 37 (193) 115-120.
38. Zhu, M.-Y., Juorio, A.V., Paterson, I.A. and Boulton, A.A., Regulation of aromatic amino acid decarboxylase by dopamine receptors in the rat brain, J. Neurochem., 58 (1992) 636-641.
39. Zhu, M.-Y., Juorio, A.V., Paterson, I.A. and Boulton, A.A., Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors, Eur. J. Pharmacol., 238 (1993) 157-164.
40. Zhu, M.-Y., Juorio, A.V., Paterson, I.A. and Boulton, A.A., (1994) Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists, Br. J. Pharmacol., 112 (1994) 23-30.
41. Ziegleder, G., Stojacic, E. and Stumpf, B., Occurrence of beta-phenylethylamine and its derivatives in cocoa and cocoa products, Z. Lebensmittel-Untersuch. Forsch., 195 (1992) 235-238.